"From routine appointments to emergency services, it’s important to get the care you need—when you need it. But we understand you may be delaying your health needs over concerns about safety. At Mount Sinai, our doctors, nurses, and staff members are working continuously to ensure your safety so that you don't have to put your health on hold."

During the past decade, Mount Sinai St. Luke's conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai St. Luke's" #1 sponsor was "Icahn School of Medicine at Mount Sinai" with 7 trials, followed by "St. Luke's-Roosevelt Hospital Center" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "AtriCure, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai St. Luke's" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Hunter College of The City University of New York" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai St. Luke's" are "Obesity" (3 trials), "Acute Coronary Syndromes" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Stroke" (1 trials) and "Binge Eating Disorder" (1 trials). Many other conditions were trialed in "Mount Sinai St. Luke's" in a lesser frequency.

Most popular intervention types in "Mount Sinai St. Luke's" are "Drug" (12 trials), "Behavioral" (6 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Dexamethasone" (2 trials), "Home Palliative Care" (2 trials), "3D conformal or intensity modulated radiotherapy" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai St. Luke's" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mount Sinai St. Luke's". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Mount Sinai St. Luke's, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai St. Luke's, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".